Chanell S Williams, | |
65 Bergen St, Newark, NJ 07107-3001 | |
(973) 972-4307 | |
Not Available |
Full Name | Chanell S Williams |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 65 Bergen St, Newark, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114779840 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Chanell S Williams, 65 Bergen St, Newark, NJ 07107-3001 Ph: (973) 972-4307 | Chanell S Williams, 65 Bergen St, Newark, NJ 07107-3001 Ph: (973) 972-4307 |
News Archive
Our response to societal pressures about vaccination has a direct effect on the spread of pediatric infectious diseases in areas where inoculation is not mandatory, says new research published this week in Proceedings of the Royal Society B.
Forest Laboratories, Inc. and Clinical Data, Inc. today announced that they have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics, for $30.00 per share in cash plus contingent consideration of up to $6.00 per share that may be paid upon achievement of certain commercial milestones related to Viibryd.
Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today that it has priced its public offering of 10,000,000 common shares at $5.75 per common share. Sinovac has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,500,000 common shares on the same terms and conditions.
Researchers have shown that a single nucleotide change in a gene that affects production of hepcidin-a peptide involved in inflammation, immunity, and control of iron levels-is associated with greater susceptibility to extrapulmonary tuberculosis.
› Verified 3 days ago